Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population

Arthritis and Rheumatism

Volumn 60, Issue 6, 2009, Pages 1845-1850

  Ito, Ikue ^a   Kawaguchi, Yasushi ^b   Kawasaki, Aya ^a   Hasegawa, Minoru ^c   Ohashi, Jun ^a   Hikami, Koki ^a   Kawamoto, Manabu ^b   Fujimoto, Manabu ^c   Takehara, Kazuhiko ^c   Sato, Shinichi ^d   Hara, Masako ^b   Tsuchiya, Naoyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA TOPOISOMERASE; GENE PRODUCT; INTERFERON; INTERFERON REGULATORY FACTOR 5; MESSENGER RNA; TRANSPORTIN 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; IRF5 GENE; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TNPO3 GENE;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERFERON REGULATORY FACTORS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SCLERODERMA, SYSTEMIC;

EID: 66449100302     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24600     Document Type: Article

References (15)

1. Mayes MD, Trojanowska M. Genetic factors in systemic sclerosis. Arthritis Res Ther 2007;9 Suppl 2:S5.
2. Duan H, Fleming J, Pritchard DK, Amon LM, Xue J, Arnett HA, et al. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma. Arthritis Rheum 2008;58:1465-1474
3. Kyogoku C, Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 2007;8: 445-455 (Pubitemid 47365611)
4. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006;38:550-555
5. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007;104:6758-6763 (Pubitemid 47175574)
6. Ferreiro-Neira I, Calaza M, Alonso-Perez E, Marchini M, Scorza R, Sebastiani GD, et al. Opposed independent effects and epistasis in the complex association of IRF5 to SLE. Genes Immun 2007;8:429-438 (Pubitemid 47177133)
7. Kawasaki A, Kyogoku C, Ohashi J, Miyashita R, Hikami K, Kusaoi M, et al. Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms. Arthritis Rheum 2008;58:826-834
8. Kelly JA, Kelley JM, Kaufman KM, Kilpatrick J, Bruner GR, Merrill JT, et al. Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun 2008;9:187-194
9. Dieude P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 2009;60:225-233
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-590
11. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205 (Pubitemid 18073738)
12. Ohashi J, Yamamoto S, Tsuchiya N, Hatta Y, Komata T, Matsushita M, et al. Comparison of statistical power between 2 X 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann Hum Genet 2001;65(Part 2):197-206. (Pubitemid 32452121)
13. Hugle T, Gratzl S, Daikeler T, Frey D, Tyndall A, Walker UA. Sclerosing skin disorders in association with multiple sclerosis: coincidence, underlying autoimmune pathology, or interferon induced? Ann Rheum Dis 2009;68:47-50.
14. Lai MC, Lin RI, Huang SY, Tsai CW, Tarn WY. A human importin-β family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins. J Biol Chem 2000;275: 7950-7957 (Pubitemid 30159704)
15. Kim D, Peck A, Santer D, Patole P, Schwartz SM, Molitor JA, et al. Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-α activity with lung fibrosis. Arthritis Rheum 2008;58:2163-2173